Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: observations from the CREDO-Kyoto Registry Cohort-2.

by Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, Yutaka Furukawa, Yoshihisa Nakagawa, Kazushige Kadota, Kyohei Yamaji, Kenji Ando, Satoshi Shizuta, Hiroki Shiomi, Tomohisa Tada, Junichi Tazaki, Yoshihiro Kato, Mamoru Hayano, Mitsuru Abe, Takashi Tamura, Manabu Shirotani, Shinji Miki, Mitsuo Matsuda, Mamoru Takahashi, Katsuhisa Ishii, Masaru Tanaka, Takeshi Aoyama, Osamu Doi, Ryuichi Hattori, Masayuki Kato, Satoru Suwa, Akinori Takizawa, Yoshiki Takatsu, Eiji Shinoda, Hiroshi Eizawa, Teruki Takeda, Jong-Dae Lee, Moriaki Inoko, Hisao Ogawa, Shuichi Hamasaki, Minoru Horie, Ryuji Nohara, Hirofumi Kambara, Hisayoshi Fujiwara, Kazuaki Mitsudo, Masakiyo Nobuyoshi, Toru Kita, Adnan Kastrati, Takeshi Kimura, CREDO-Kyoto PCI/CABG registry cohort-2 investigators
Published 2015-01-01